Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes
To determine rates of eye examinations and diabetic eye disease in the first 5 years after diagnosis of type 2 diabetes (DM2) among continuously insured adults. Retrospective, longitudinal cohort study. Insured patients aged 40 years or older with newly diagnosed DM2 (n = 42 684), and control patien...
Gespeichert in:
Veröffentlicht in: | Ophthalmology retina 2021-02, Vol.5 (2), p.160-168 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 168 |
---|---|
container_issue | 2 |
container_start_page | 160 |
container_title | Ophthalmology retina |
container_volume | 5 |
creator | Gange, William S. Xu, Benjamin Y. Lung, Khristina Toy, Brian C. Seabury, Seth A. |
description | To determine rates of eye examinations and diabetic eye disease in the first 5 years after diagnosis of type 2 diabetes (DM2) among continuously insured adults.
Retrospective, longitudinal cohort study.
Insured patients aged 40 years or older with newly diagnosed DM2 (n = 42 684), and control patients without diabetes matched on age, sex, and race were identified from a nationwide commercial claims database containing data from 2007 to 2015.
All patients were tracked for 6 years: 1 year before and 5 years after the index diabetes diagnosis. Receipt of eye care for individual patients was identified using International Classification of Diseases 9th edition (ICD-9) procedure codes or Current Procedural Terminology (CPT) codes indicating an eye examination, as well as encounters indicating the patient was seen by an ophthalmologist. A diagnosis of diabetic eye disease was determined by using ICD-9 codes.
Outcome measures included annual receipt of eye care and development of diabetic eye disease, namely, diabetic retinopathy (DR). Associations between these outcomes and demographic factors were tested with multivariable logistic regression.
Diabetic patients received more eye examinations than controls in each year, but no more than 40.4% of diabetic patients received an examination in any given year. Patients with Medicare Advantage received fewer eye examinations at 5 years (odds ratio [OR], 0.79; P < 0.01) than those with private insurance but were less likely to develop DR (OR, 0.71; P < 0.01). Hispanic patients had higher rates of DR (OR, 1.60; P < 0.01) and received fewer eye examinations (OR, 0.75; P < 0.01) at 5 years compared with White patients. Men received fewer eye examinations (OR, 0.84; P < 0.01) and were more likely to develop DR at 5 years (OR, 1.17; P < 0.01) than women. Patients with higher education were more likely to receive an eye examination and less likely to develop DR.
The majority of diabetic patients do not receive adequate eye care within the 5 years after initial diabetes diagnosis despite having insurance. Efforts should be made to improve adherence to screening guidelines, especially for vulnerable populations. |
doi_str_mv | 10.1016/j.oret.2020.07.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11318347</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468653020302827</els_id><sourcerecordid>2423517252</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-6e3546c55d8d4e16b90b1a5e3b4b34501af530be65e717043726237f46c6a4d93</originalsourceid><addsrcrecordid>eNp9UUtrGzEQFqWlCWn-QA9Fx168Hb0dKJRiJ00gpKWkZ6HVzjoy65UryQn-95FrJ6SXnEbM95jRfIR8ZNAwYPrLsokJS8OBQwOmAZBvyDGXejrRSsDbF-8jcprzEgDYlGtt4D05ErwCSslj0v92BTONPT3fIp25hNSNHZ0H12IJ_l93HjK6XIFVHBf0asybhB395UrAsWT6EModvcGHYbuTLcaYK3q7XSPlBx_MH8i73g0ZTw_1hPy5OL-dXU6uf_64mn2_nnipdJloFEpqr1Q37SQy3Z5By5xC0cpWSAXM9fVDLWqFhhmQwnDNhemrRjvZnYkT8m3vu960K-x8XTC5wa5TWLm0tdEF-z8yhju7iPeWMcGmQprq8PngkOLfDeZiVyF7HAY3YtxkyyUXihmueKXyPdWnmHPC_nkOA7sLyS7tLiS7C8mCsTWkKvr0csNnyVMklfB1T8B6p_uAyWZfD-2xCwl9sV0Mr_k_AgSyolo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2423517252</pqid></control><display><type>article</type><title>Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Gange, William S. ; Xu, Benjamin Y. ; Lung, Khristina ; Toy, Brian C. ; Seabury, Seth A.</creator><creatorcontrib>Gange, William S. ; Xu, Benjamin Y. ; Lung, Khristina ; Toy, Brian C. ; Seabury, Seth A.</creatorcontrib><description><![CDATA[To determine rates of eye examinations and diabetic eye disease in the first 5 years after diagnosis of type 2 diabetes (DM2) among continuously insured adults.
Retrospective, longitudinal cohort study.
Insured patients aged 40 years or older with newly diagnosed DM2 (n = 42 684), and control patients without diabetes matched on age, sex, and race were identified from a nationwide commercial claims database containing data from 2007 to 2015.
All patients were tracked for 6 years: 1 year before and 5 years after the index diabetes diagnosis. Receipt of eye care for individual patients was identified using International Classification of Diseases 9th edition (ICD-9) procedure codes or Current Procedural Terminology (CPT) codes indicating an eye examination, as well as encounters indicating the patient was seen by an ophthalmologist. A diagnosis of diabetic eye disease was determined by using ICD-9 codes.
Outcome measures included annual receipt of eye care and development of diabetic eye disease, namely, diabetic retinopathy (DR). Associations between these outcomes and demographic factors were tested with multivariable logistic regression.
Diabetic patients received more eye examinations than controls in each year, but no more than 40.4% of diabetic patients received an examination in any given year. Patients with Medicare Advantage received fewer eye examinations at 5 years (odds ratio [OR], 0.79; P < 0.01) than those with private insurance but were less likely to develop DR (OR, 0.71; P < 0.01). Hispanic patients had higher rates of DR (OR, 1.60; P < 0.01) and received fewer eye examinations (OR, 0.75; P < 0.01) at 5 years compared with White patients. Men received fewer eye examinations (OR, 0.84; P < 0.01) and were more likely to develop DR at 5 years (OR, 1.17; P < 0.01) than women. Patients with higher education were more likely to receive an eye examination and less likely to develop DR.
The majority of diabetic patients do not receive adequate eye care within the 5 years after initial diabetes diagnosis despite having insurance. Efforts should be made to improve adherence to screening guidelines, especially for vulnerable populations.]]></description><identifier>ISSN: 2468-6530</identifier><identifier>ISSN: 2468-7219</identifier><identifier>EISSN: 2468-6530</identifier><identifier>DOI: 10.1016/j.oret.2020.07.004</identifier><identifier>PMID: 32653554</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; California - epidemiology ; Cost-Benefit Analysis ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - economics ; Diabetic Retinopathy - economics ; Diabetic Retinopathy - epidemiology ; Diabetic Retinopathy - therapy ; Follow-Up Studies ; Humans ; Mass Screening - economics ; Medicare - statistics & numerical data ; Middle Aged ; Patient Compliance - statistics & numerical data ; Retrospective Studies ; Time Factors ; United States</subject><ispartof>Ophthalmology retina, 2021-02, Vol.5 (2), p.160-168</ispartof><rights>2020 American Academy of Ophthalmology</rights><rights>Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-6e3546c55d8d4e16b90b1a5e3b4b34501af530be65e717043726237f46c6a4d93</citedby><cites>FETCH-LOGICAL-c456t-6e3546c55d8d4e16b90b1a5e3b4b34501af530be65e717043726237f46c6a4d93</cites><orcidid>0000-0002-0154-7089</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32653554$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gange, William S.</creatorcontrib><creatorcontrib>Xu, Benjamin Y.</creatorcontrib><creatorcontrib>Lung, Khristina</creatorcontrib><creatorcontrib>Toy, Brian C.</creatorcontrib><creatorcontrib>Seabury, Seth A.</creatorcontrib><title>Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes</title><title>Ophthalmology retina</title><addtitle>Ophthalmol Retina</addtitle><description><![CDATA[To determine rates of eye examinations and diabetic eye disease in the first 5 years after diagnosis of type 2 diabetes (DM2) among continuously insured adults.
Retrospective, longitudinal cohort study.
Insured patients aged 40 years or older with newly diagnosed DM2 (n = 42 684), and control patients without diabetes matched on age, sex, and race were identified from a nationwide commercial claims database containing data from 2007 to 2015.
All patients were tracked for 6 years: 1 year before and 5 years after the index diabetes diagnosis. Receipt of eye care for individual patients was identified using International Classification of Diseases 9th edition (ICD-9) procedure codes or Current Procedural Terminology (CPT) codes indicating an eye examination, as well as encounters indicating the patient was seen by an ophthalmologist. A diagnosis of diabetic eye disease was determined by using ICD-9 codes.
Outcome measures included annual receipt of eye care and development of diabetic eye disease, namely, diabetic retinopathy (DR). Associations between these outcomes and demographic factors were tested with multivariable logistic regression.
Diabetic patients received more eye examinations than controls in each year, but no more than 40.4% of diabetic patients received an examination in any given year. Patients with Medicare Advantage received fewer eye examinations at 5 years (odds ratio [OR], 0.79; P < 0.01) than those with private insurance but were less likely to develop DR (OR, 0.71; P < 0.01). Hispanic patients had higher rates of DR (OR, 1.60; P < 0.01) and received fewer eye examinations (OR, 0.75; P < 0.01) at 5 years compared with White patients. Men received fewer eye examinations (OR, 0.84; P < 0.01) and were more likely to develop DR at 5 years (OR, 1.17; P < 0.01) than women. Patients with higher education were more likely to receive an eye examination and less likely to develop DR.
The majority of diabetic patients do not receive adequate eye care within the 5 years after initial diabetes diagnosis despite having insurance. Efforts should be made to improve adherence to screening guidelines, especially for vulnerable populations.]]></description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>California - epidemiology</subject><subject>Cost-Benefit Analysis</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - economics</subject><subject>Diabetic Retinopathy - economics</subject><subject>Diabetic Retinopathy - epidemiology</subject><subject>Diabetic Retinopathy - therapy</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Mass Screening - economics</subject><subject>Medicare - statistics & numerical data</subject><subject>Middle Aged</subject><subject>Patient Compliance - statistics & numerical data</subject><subject>Retrospective Studies</subject><subject>Time Factors</subject><subject>United States</subject><issn>2468-6530</issn><issn>2468-7219</issn><issn>2468-6530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UUtrGzEQFqWlCWn-QA9Fx168Hb0dKJRiJ00gpKWkZ6HVzjoy65UryQn-95FrJ6SXnEbM95jRfIR8ZNAwYPrLsokJS8OBQwOmAZBvyDGXejrRSsDbF-8jcprzEgDYlGtt4D05ErwCSslj0v92BTONPT3fIp25hNSNHZ0H12IJ_l93HjK6XIFVHBf0asybhB395UrAsWT6EModvcGHYbuTLcaYK3q7XSPlBx_MH8i73g0ZTw_1hPy5OL-dXU6uf_64mn2_nnipdJloFEpqr1Q37SQy3Z5By5xC0cpWSAXM9fVDLWqFhhmQwnDNhemrRjvZnYkT8m3vu960K-x8XTC5wa5TWLm0tdEF-z8yhju7iPeWMcGmQprq8PngkOLfDeZiVyF7HAY3YtxkyyUXihmueKXyPdWnmHPC_nkOA7sLyS7tLiS7C8mCsTWkKvr0csNnyVMklfB1T8B6p_uAyWZfD-2xCwl9sV0Mr_k_AgSyolo</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Gange, William S.</creator><creator>Xu, Benjamin Y.</creator><creator>Lung, Khristina</creator><creator>Toy, Brian C.</creator><creator>Seabury, Seth A.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0154-7089</orcidid></search><sort><creationdate>20210201</creationdate><title>Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes</title><author>Gange, William S. ; Xu, Benjamin Y. ; Lung, Khristina ; Toy, Brian C. ; Seabury, Seth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-6e3546c55d8d4e16b90b1a5e3b4b34501af530be65e717043726237f46c6a4d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>California - epidemiology</topic><topic>Cost-Benefit Analysis</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - economics</topic><topic>Diabetic Retinopathy - economics</topic><topic>Diabetic Retinopathy - epidemiology</topic><topic>Diabetic Retinopathy - therapy</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Mass Screening - economics</topic><topic>Medicare - statistics & numerical data</topic><topic>Middle Aged</topic><topic>Patient Compliance - statistics & numerical data</topic><topic>Retrospective Studies</topic><topic>Time Factors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gange, William S.</creatorcontrib><creatorcontrib>Xu, Benjamin Y.</creatorcontrib><creatorcontrib>Lung, Khristina</creatorcontrib><creatorcontrib>Toy, Brian C.</creatorcontrib><creatorcontrib>Seabury, Seth A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Ophthalmology retina</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gange, William S.</au><au>Xu, Benjamin Y.</au><au>Lung, Khristina</au><au>Toy, Brian C.</au><au>Seabury, Seth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes</atitle><jtitle>Ophthalmology retina</jtitle><addtitle>Ophthalmol Retina</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>5</volume><issue>2</issue><spage>160</spage><epage>168</epage><pages>160-168</pages><issn>2468-6530</issn><issn>2468-7219</issn><eissn>2468-6530</eissn><abstract><![CDATA[To determine rates of eye examinations and diabetic eye disease in the first 5 years after diagnosis of type 2 diabetes (DM2) among continuously insured adults.
Retrospective, longitudinal cohort study.
Insured patients aged 40 years or older with newly diagnosed DM2 (n = 42 684), and control patients without diabetes matched on age, sex, and race were identified from a nationwide commercial claims database containing data from 2007 to 2015.
All patients were tracked for 6 years: 1 year before and 5 years after the index diabetes diagnosis. Receipt of eye care for individual patients was identified using International Classification of Diseases 9th edition (ICD-9) procedure codes or Current Procedural Terminology (CPT) codes indicating an eye examination, as well as encounters indicating the patient was seen by an ophthalmologist. A diagnosis of diabetic eye disease was determined by using ICD-9 codes.
Outcome measures included annual receipt of eye care and development of diabetic eye disease, namely, diabetic retinopathy (DR). Associations between these outcomes and demographic factors were tested with multivariable logistic regression.
Diabetic patients received more eye examinations than controls in each year, but no more than 40.4% of diabetic patients received an examination in any given year. Patients with Medicare Advantage received fewer eye examinations at 5 years (odds ratio [OR], 0.79; P < 0.01) than those with private insurance but were less likely to develop DR (OR, 0.71; P < 0.01). Hispanic patients had higher rates of DR (OR, 1.60; P < 0.01) and received fewer eye examinations (OR, 0.75; P < 0.01) at 5 years compared with White patients. Men received fewer eye examinations (OR, 0.84; P < 0.01) and were more likely to develop DR at 5 years (OR, 1.17; P < 0.01) than women. Patients with higher education were more likely to receive an eye examination and less likely to develop DR.
The majority of diabetic patients do not receive adequate eye care within the 5 years after initial diabetes diagnosis despite having insurance. Efforts should be made to improve adherence to screening guidelines, especially for vulnerable populations.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32653554</pmid><doi>10.1016/j.oret.2020.07.004</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0154-7089</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2468-6530 |
ispartof | Ophthalmology retina, 2021-02, Vol.5 (2), p.160-168 |
issn | 2468-6530 2468-7219 2468-6530 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11318347 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Aged Aged, 80 and over California - epidemiology Cost-Benefit Analysis Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - economics Diabetic Retinopathy - economics Diabetic Retinopathy - epidemiology Diabetic Retinopathy - therapy Follow-Up Studies Humans Mass Screening - economics Medicare - statistics & numerical data Middle Aged Patient Compliance - statistics & numerical data Retrospective Studies Time Factors United States |
title | Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T17%3A22%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rates%20of%20Eye%20Care%20and%20Diabetic%20Eye%20Disease%20among%20Insured%20Patients%20with%20Newly%20Diagnosed%20Type%202%20Diabetes&rft.jtitle=Ophthalmology%20retina&rft.au=Gange,%20William%20S.&rft.date=2021-02-01&rft.volume=5&rft.issue=2&rft.spage=160&rft.epage=168&rft.pages=160-168&rft.issn=2468-6530&rft.eissn=2468-6530&rft_id=info:doi/10.1016/j.oret.2020.07.004&rft_dat=%3Cproquest_pubme%3E2423517252%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2423517252&rft_id=info:pmid/32653554&rft_els_id=S2468653020302827&rfr_iscdi=true |